Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

With long COVID patients becoming increasingly frustrated with the lack of available treatments, some have now taken to traveling to Cyprus, Germany, and Switzerland for experimental "blood washing," ...

DUBLIN, May 29, 2019 /PRNewswire/ -- The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate ...

Many patients who still have symptoms weeks or months after recovering from COVID-19 are spending hefty sums to travel for treatments like apheresis and combination antithrombotic therapy that have ...

NEW YORK, Sept. 21, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment: Equipment for Therapeutic ...